Cathie Wood’s ARK Invest and other institutional investors were slated to take a steep hit as shares of Teladoc Health plummeted 44% on Thursday following a deeper-than-expected earnings miss and guidance cut.
Teladoc (ticker: TDOC) posted a loss of $41.58 a share for the first quarter — significantly wider than analysts’ forecasts for a loss of just 60 cents. The company also revised its revenue expectations for the year down to a range between $2.4 billion and $2.5 billion, under previous guidance for $2.55 billion to $2.65…